The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
X versus XELOX versus PF in definitive concurrent chemoradiotherapy (DCRT) for local advanced squamous esophageal cancer (ESCC): Update from a multicenter, open-label, randomized III trial, CRTCOESC trial.
 
Ruinuo Jia
No Relationships to Disclose
 
Tanyou Shan
No Relationships to Disclose
 
Lixin Wan
No Relationships to Disclose
 
Anping Zheng
No Relationships to Disclose
 
Shuang Hui
No Relationships to Disclose
 
Zhiqiao Xu
No Relationships to Disclose
 
Feng Wang
No Relationships to Disclose
 
Guobao Zheng
No Relationships to Disclose
 
Ping Lu
No Relationships to Disclose
 
Guifang Zhang
No Relationships to Disclose
 
Yingjuan Zheng
No Relationships to Disclose
 
Yanhui Cui
No Relationships to Disclose
 
Xiaoyong Luo
No Relationships to Disclose
 
Weiguo Zhang
No Relationships to Disclose
 
Wanying Li
No Relationships to Disclose
 
Ruonan Li
No Relationships to Disclose
 
Fuyou Zhou
No Relationships to Disclose
 
Shegan Gao
No Relationships to Disclose